tirzepatide and tamoxifen Scientists have discovered that tirzepatide—an FDA-approved drug for diabetes weight loss (Mounjaro, Zepbound)—can also shrink breast cancer tumors in obese mice. Presented at ENDO 2025, the University of Michigan study showed Highlighting 3 ongoing clinical trials
Description
Extra body weight increases pressure on joints and triggers inflammatory responses that worsen arthritis
Check our GLP-1 page for exceptional pharmaceutical services and personalized care

Theres a direct connection between obesity and sleep apneaand a new FDA-approved weight loss medication is helping to treat both

Discover how microdosing with GLP-1 meds can manage appetite and support blood sugar

Regulator approval means patients who meet criteria will be able to purchase tablets with private prescription

It's generally safe to have coffee while taking Ozempic
